Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 884967

Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection


Mihaljević-Peleš, Alma; Šagud, Marina; Filipčić Šimunović, Ivona; Grošić, Vladimir; Pedišić, Ivana; Emsley, Robin
Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection // Psychiatria Danubina, 28 (2016), 3; 263-272 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 884967 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection

Autori
Mihaljević-Peleš, Alma ; Šagud, Marina ; Filipčić Šimunović, Ivona ; Grošić, Vladimir ; Pedišić, Ivana ; Emsley, Robin

Izvornik
Psychiatria Danubina (0353-5053) 28 (2016), 3; 263-272

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
schizophrenia - risperidone long-acting injectable (RLAI) - non-adherence – remission - employment in schizophrenia

Sažetak
While numerous studies have confirmed the efficacy of risperidone long-acting injectable (RLAI) on many clinical outcomes in patients with schizophrenia, there is no data regarding its influence on employment status. This was a 12-month observational study with flexible doses of RLAI on a Croatian population of patients with schizophrenia and other psychoses. Visits were at baseline and after 1, 3, 6 and 12 months of treatment. Treatment response was evaluated using Clinical Global Impression of Illness Severity (CGI-S) and Improvement (CGI-I) scales, while remission was defined by 8 items of Positive and Negative Syndrome Scale (PANSS). Employment status was determined at baseline and at study endpoint. A total of 362 patients were included, with a median age of 37 (interquartile range 29-47) years, 63.5 % were males and 67.4% were hospitalised at baseline. Overall 258 (71.3%) patients completed the study. Improvements in CGI-S scores from baseline were significant (p<0.001) at all visits. Remission criteria were met in 9 (2.5%) patients at baseline, and in 199 (54.9%) at endpoint, while 144 patients (52.7%) achieved symptomatic remission. Female patients were five times more likely to achieve symptomatic remission (OR=5.2 ; 95%CI=2.64-10.19). At baseline, 74/362 (20.4%) patients were employed, compared to 77/257 (30.0%) at endpoint (p<0.001). Adverse events were spontaneously reported in 55 (15.2%) patients. Three patients died (judged not to be related to RLAI) and one patient committed homicide. Patients treated with RLAI had significant improvements in CGI-S scale scores, hospitalization status, rates of remission and employment status, indicating the benefits of continuous treatment over time. Further studies on the comparative impact of different treatment strategies on functional recovery are needed.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Opća bolnica Šibenik,
Klinički bolnički centar Zagreb,
Psihijatrijska bolnica "Sveti Ivan" Zagreb

Citiraj ovu publikaciju

Mihaljević-Peleš, Alma; Šagud, Marina; Filipčić Šimunović, Ivona; Grošić, Vladimir; Pedišić, Ivana; Emsley, Robin
Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection // Psychiatria Danubina, 28 (2016), 3; 263-272 (međunarodna recenzija, članak, znanstveni)
Mihaljević-Peleš, A., Šagud, M., Filipčić Šimunović, I., Grošić, V., Pedišić, I. & Emsley, R. (2016) Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection. Psychiatria Danubina, 28 (3), 263-272.
@article{article, year = {2016}, pages = {263-272}, keywords = {schizophrenia - risperidone long-acting injectable (RLAI) - non-adherence – remission - employment in schizophrenia}, journal = {Psychiatria Danubina}, volume = {28}, number = {3}, issn = {0353-5053}, title = {Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection}, keyword = {schizophrenia - risperidone long-acting injectable (RLAI) - non-adherence – remission - employment in schizophrenia} }
@article{article, year = {2016}, pages = {263-272}, keywords = {schizophrenia - risperidone long-acting injectable (RLAI) - non-adherence – remission - employment in schizophrenia}, journal = {Psychiatria Danubina}, volume = {28}, number = {3}, issn = {0353-5053}, title = {Remission and employment status in schizophrenia and other psychoses : One-year prospective study in Croatian patients treated with risperidone long acting injection}, keyword = {schizophrenia - risperidone long-acting injectable (RLAI) - non-adherence – remission - employment in schizophrenia} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • Social Science Citation Index (SSCI)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font